Does Triazolam Interact with Erythromycin Ethylsuccinate?
CDI records a major classification for Triazolam and Erythromycin Ethylsuccinate. The stored summary is: Erythromycin decreases clearance of triazolam and may increase its pharmacologic effect. The mechanism involves cyp3a inhibition by erythromycin. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Major
- Triazolam Class
- Benzodiazepine
- Management
- Close medical supervision required
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
CYP3A inhibition by erythromycin
What To Tell Your Doctor or Pharmacist
If you are taking Triazolam and your doctor is considering prescribing Erythromycin Ethylsuccinate (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask how frequently you should be monitored while these are co-prescribed
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider